{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:14:32Z","timestamp":1790939672547,"version":"4.1.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,5,1]]},"abstract":"<jats:p>Idiopathic hyperaldosteronism (IHA) is characterized by hypertension with excessive production of aldosterone, potassium loss, and suppression of the renin-angiotensin system. We compared activity of aldosterone synthase and expression of CYP11B2 messenger RNA (mRNA) in mononuclear leukocytes (MNL) from patients with IHA to findings in leukocytes from patients with aldosterone-producing adenoma and normal controls. Aldosterone synthase activity was estimated from conversion of [14C]deoxycorticosterone to[ 14C]aldosterone. Levels of CYP11B2 mRNA were determined by competitive PCR. In the same subjects, we sought the chimeric CYP11B1\/CYP11B2 that is candidate gene for glucocorticoid-remediable hyperaldosteronism. Southern blot analysis and a long PCR method were used to detect the chimeric gene. Direct sequencing of the CYP11B2 also was performed. No chimeric genes or mutations in the coding region of the CYP11B2 were found in genomic DNA from these patients. However, both aldosterone synthase activity and CYP11B2 mRNA expression were greater in mononuclear leukocytes of patients with IHA than those of patients with aldosterone-producing adenoma or controls. These results suggest that regulatory factors of the CYP11B2 gene, e.g. unidentified aldosterone-stimulating substances or abnormalities in the promoter region of the CYP11B2 gene in patients with IHA resulting in oversecretion, may cause overexpression of mRNA of CYP11B2.<\/jats:p>","DOI":"10.1210\/jcem.84.5.5671","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:04:37Z","timestamp":1389200677000},"page":"1633-1637","source":"Crossref","is-referenced-by-count":1,"title":["Genetic Analysis of Aldosterone Synthase in Patients with Idiopathic Hyperaldosteronism1"],"prefix":"10.1210","volume":"84","author":[{"given":"Yoshiyu","family":"Takeda","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine (Y.T., K.F., H.M.), Kanazawa 920, Japan"},{"name":"Department of Health Sciences (Y.T.), School of Medicine, Kanazawa University, Kanazawa 920, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine (Y.T., K.F., H.M.), Kanazawa 920, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Inaba","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine (S.I., I.M.), Fukui Medical School, Fukui 910\u201311, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Miyamori","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine (S.I., I.M.), Fukui Medical School, Fukui 910\u201311, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine (Y.T., K.F., H.M.), Kanazawa 920, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618163698000_R1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(94)93003-1","article-title":"Mineralocorticoid hypertension.","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"2020071618163698000_R2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1530\/acta.0.1260484","article-title":"Urinary excretion of 19-noraldosterone, 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.","volume":"126","author":"Takeda","year":"1992","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071618163698000_R3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex.","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2020071618163698000_R4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJM199407283310408","article-title":"Disorders of aldosterone biosynthesis and action.","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071618163698000_R5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"2020071618163698000_R6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0006-291X(92)92286-7","article-title":"The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity.","volume":"189","author":"Miyahara","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071618163698000_R7","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071618163698000_R8","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1074\/jbc.270.28.16555","article-title":"Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension.","volume":"270","author":"Cover","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071618163698000_R9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jcem.80.3.7883820","article-title":"Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension?","volume":"80","author":"Fardella","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R10","first-page":"E388","article-title":"Characterization of aldosterone binding sites in circulating human mononuclear leukocytes","volume":"248","author":"Armanini","year":"1985","journal-title":"Am J Physiol."},{"key":"2020071618163698000_R11","first-page":"2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin.","volume":"81","author":"Takeda","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R12","first-page":"783","article-title":"Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma.","volume":"80","author":"Wu","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-291X(05)81058-7","article-title":"Cloning and expression of cDNA for human cytochrome P450aldo as related to primary aldosteronism.","volume":"173","author":"Kawamoto","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071618163698000_R14","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1172\/JCI116428","article-title":"Gene expression of the renin-angiotensin system in human tissues.","volume":"91","author":"Paul","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071618163698000_R15","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/endo.135.5.7956952","article-title":"Synthesis of corticosterone in the vascular wall.","volume":"135","author":"Takeda","year":"1994","journal-title":"Endocrinology"},{"key":"2020071618163698000_R16","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/bbrc.1995.1225","article-title":"A new test for familial hyperaldosteronism type I aids in the detection of curable hypertension.","volume":"207","author":"Jonsson","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071618163698000_R17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0039-128X(94)00023-6","article-title":"Inborn errors of aldosterone biosynthesis in humans.","volume":"60","author":"Shizuta","year":"1995","journal-title":"Steroids"},{"key":"2020071618163698000_R18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1210\/jcem-69-6-1148","article-title":"Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.","volume":"69","author":"Solish","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0960-0760(91)90347-8","article-title":"Extraadrenal expression of steroid 21-hydroxylase and 11\u03b2-hydroxylase by a benign testicular Leydig cell tumor.","volume":"39","author":"Namiki","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071618163698000_R20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","article-title":"Production of aldosterone in isolated rat blood vessels.","volume":"25","author":"Takeda","year":"1995","journal-title":"Hypertension"},{"key":"2020071618163698000_R21","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/endo.138.8.5326","article-title":"Aldosterone biosynthesis in the rat brain.","volume":"138","author":"Gomez-Sanchez","year":"1997","journal-title":"Endocrinology"},{"key":"2020071618163698000_R22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.27.3.399","article-title":"Renin is expressed in rat macrophage\/monocyte cells.","volume":"27","author":"Iwai","year":"1996","journal-title":"Hypertension"},{"key":"2020071618163698000_R23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.V78.3.688.688","article-title":"Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4)m IL5, and \u03b3-interferon, but not IL-2 by activated murine T cells.","volume":"78","author":"Araneo","year":"1991","journal-title":"Blood"},{"key":"2020071618163698000_R24","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1210\/endo.138.12.5562","article-title":"Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene.","volume":"138","author":"Shozu","year":"1997","journal-title":"Endocrinology"},{"key":"2020071618163698000_R25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0960-0760(90)90407-C","article-title":"Synthesis of 19-noraldosterone, 18-hydroxy-19-norcorticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma.","volume":"37","author":"Takeda","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071618163698000_R26"},{"key":"2020071618163698000_R27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.CIR.97.6.569","article-title":"Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function.","volume":"97","author":"Kupari","year":"1998","journal-title":"Circulation"},{"key":"2020071618163698000_R28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.HYP.32.2.198","article-title":"Structural analysis and evaluation of the aldosterone synthase gene in hypertension.","volume":"32","author":"Brand","year":"1998","journal-title":"Hypertension"},{"key":"2020071618163698000_R29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2796.1998.00308.x","article-title":"Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males.","volume":"244","author":"Hautanen","year":"1998","journal-title":"J Intern Med"},{"key":"2020071618163698000_R30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00208293","article-title":"A polymorphic poly-A sequence in the 5\u2032 region of the aldosynthase (CYP11B2) gene may be useful in genetic diagnosis of 11\u03b2-hydroxylase 13 genes defects.","volume":"94","author":"Clot","year":"1994","journal-title":"Hum Genet"},{"key":"2020071618163698000_R31","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low renin activity relieved by dexamethasone.","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"2020071618163698000_R32","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI118279","article-title":"Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.","volume":"96","author":"Pascoe","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071618163698000_R33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0039-128X(94)00013-3","article-title":"Primary aldosteronism-some genetic, morphological, and biochemical aspects of subtypes.","volume":"65","author":"Gordon","year":"1995","journal-title":"Steroids"},{"key":"2020071618163698000_R34","first-page":"4310","article-title":"Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.","volume":"81","author":"Carroll","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R35","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R36","first-page":"2585","article-title":"Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.","volume":"83","author":"Beuschlein","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618163698000_R37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type I.","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"2020071618163698000_R38","first-page":"4347","article-title":"Genetic variation in P45011AS in Chilean patients with low renin hypertension.","volume":"81","author":"Fardella","year":"1996","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/5\/1633\/9215154\/jcem1633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/5\/1633\/9215154\/jcem1633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:49:49Z","timestamp":1594957789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/84\/5\/1633\/2864281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5,1]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.84.5.5671","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5,1]]}}}